Company Filing History:
Years Active: 2020
Title: Daphna Zaaroor Regev: Innovator in Seizure Treatment
Introduction
Daphna Zaaroor Regev is a notable inventor based in Nofit, Israel. She has made significant contributions to the field of medical science, particularly in the treatment of seizures. Her innovative work has led to the development of a unique preparation that addresses this critical health issue.
Latest Patents
Daphna holds a patent for a "Serine glycerophospholipid preparation and method for treatment of seizures." This preparation comprises a non-mammalian derived mixture of serine glycerophospholipids (PS) conjugates. The mixture includes Eicosapentaenoic acid (EPA) conjugated to PS and Docosahexaenoic acid (DHA) conjugated to PS. This invention provides methods for the treatment and/or prevention of seizures, showcasing her commitment to advancing medical treatments.
Career Highlights
Daphna is associated with Enzymotec Ltd., a company known for its innovative health solutions. Her work at the company has been instrumental in developing new therapeutic approaches. With her expertise, she has contributed to the advancement of medical science and improved patient outcomes.
Collaborations
Daphna has collaborated with notable colleagues, including Yael Herzog and Robert Chudnow. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.
Conclusion
Daphna Zaaroor Regev is a pioneering inventor whose work in seizure treatment exemplifies the impact of innovation in healthcare. Her contributions continue to inspire advancements in medical science and improve the lives of those affected by seizures.